Cited by 1,685T-cell and B-cell ImmunologyImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

CTLA-4 is a second receptor for the B cell activation antigen B7.

Open access

Linsley, P S, Brady, W, Urnes, M, Grosmaire, L S, Damle, N K, Ledbetter, J A·1991·The Journal of experimental medicine

Open this paper in CoChat — free account Open PDF

Abstract

Functional interactions between T and B lymphocytes are necessary for optimal activation of an immune response. Recently, the T lymphocyte receptor CD28 was shown to bind the B7 counter-receptor on activated B lymphocytes, and subsequently to costimulate interleukin 2 production and T cell proliferation. CTLA-4 is a predicted membrane receptor from cytotoxic T cells that is homologous to CD28 and whose gene maps to the same chromosomal band as the gene for CD28. It is not known, however, if CD28 and CTLA-4 also share functional properties. To investigate functional properties of CTLA-4, we have produced a soluble genetic fusion between the extracellular domain of CTLA-4 and an immunoglobulin C gamma chain. Here, we show that the fusion protein encoded by this construct, CTLA4Ig, bound specifically to B7-transfected Chinese hamster ovary cells and to lymphoblastoid cells. CTLA4Ig also immunoprecipitated B7 from cell surface 125I-labeled extracts of these cells. The avidity of 125I-labeled B7Ig fusion protein for immobilized CTLA4Ig was estimated (Kd approximately 12 nM). Finally, we show that CTLA4Ig was a potent inhibitor of in vitro immune responses dependent upon cellular interactions between T and B lymphocytes. These findings provide direct evidence that, like its structural homologue CD28, CTLA-4 is able to bind the B7 counter-receptor on activated B cells. Lymphocyte interactions involving the B7 counter-receptor are functionally important for alloantigen responses in vitro.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1084/jem.174.3.561

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell Anemia
Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., & Arnheim, N. (1985) · Science · doi:10.1126/science.2999980 · Cited by 8,956
Adhesion receptors of the immune system
Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477
Approaching the asymptote? Evolution and revolution in immunology.Preprint
Janeway, C. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.003 · Cited by 3,396
The Immunoglobulin Superfamily: Domains For Cell Surface Recognition
Williams, A., & Barclay, A. N. (1988) · Annual Review of Immunology · doi:10.1146/annurev.iy.06.040188.002121 · Cited by 2,270
A cell culture model for T lymphocyte clonal anergy
Schwartz, R. H. (1990) · Science · doi:10.1126/science.2113314 · Cited by 1,857
A Theory of Self-Nonself Discrimination
Bretscher, P., & Cohn, M. (1970) · Science · doi:10.1126/science.169.3950.1042 · Cited by 1,755
A new member of the immunoglobulin superfamily—CTLA-4
Brunet, J., Denizot, F., Luciani, M., Roux-Rouquié, M., Suzan, M., Mattéi, M., & Golstein, P. (1987) · Nature · doi:10.1038/328267a0 · Cited by 1,307
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.
Linsley, P. S., Brady, W., Grosmaire, L. S., Aruffo, A. A., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.3.721 · Cited by 1,126
Self-citation
Regulation of Lymphokine Messenger RNA Stability by a Surface-Mediated T Cell Activation Pathway
Lindstein, T., June, C. H., Ledbetter, J. A., Stella, G. C. L., & Thompson, C. B. (1989) · Science · doi:10.1126/science.2540528 · Cited by 866
Self-citation
Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system.
Aruffo, A. A., & Seed, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8573 · Cited by 787

Flagged first, then by citations

Show all 41 references

Sorted by citations

Items 601–700 of 1,000

PROLONGED XENOGRAFT SURVIVAL OF ISLETS INFECTED WITH SMALL DOSES OF ADENOVIRUS EXPRESSING CTLA4Ig1
Feng, S., Quickel, R. R., Hollister‐Lock, J., McLeod, M. D., Bonner‐Weir, S., Mulligan, R. C., & Weir, G. C. (1999) · Transplantation · doi:10.1097/00007890-199906270-00016 · Cited by 50
Blockade of CD28/B7 co‐stimulation by mCTLA4‐Hγ1 inhibits antigen‐induced lung eosinophilia but not Th2 cell development or recruitment in the lung
Harris, N. L., Campbell, C., Gros, G. S. L., & Ronchese, F. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270123 · Cited by 50
Role of co-stimulation in CD8+ T cell activation
Pardigon, N. (1998) · International Immunology · doi:10.1093/intimm/10.5.619 · Cited by 50
The B7/CD28/CTLA4 T-Cell Activation Pathway: Implications for Inflammatory Lung Disease
Green, J. M. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.3.f179 · Cited by 50
Immuno-regulatory antibodies for the treatment of cancer
Honeychurch, J., Cheadle, E. J., Dovedi, S. J., & Illidge, T. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1036737 · Cited by 49
“CTLA-4 is a structural homolog of the CD28 costimulatory molecule and shares functional affinity for the B7 family molecules CD80 and CD86 [17].”
BackgroundInfluential
Immune Checkpoint PD-1/PD-L1 CTLA-4/CD80 are Blocked by Rhus verniciflua Stokes and its Active Compounds
Li, W., Kim, T. I., Kim, J. H., & Chung, H. (2019) · Molecules · doi:10.3390/molecules24224062 · Cited by 50
Absence of CTLA-4 Lowers the Activation Threshold of Primed CD8+ TCR-Transgenic T Cells: Lack of Correlation with Src Homology Domain 2-Containing Protein Tyrosine Phosphatase
Gajewski, T. F., Fallarino, F., Fields, P. E., Rivas, F. V., & Alegre, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3900 · Cited by 49
Costimulation, tolerance and ignorance of cytolytic T lymphocytes in immune responses to tumor antigens
Melero, I., Bach, N., & Chen, L. (1997) · Life Sciences · doi:10.1016/s0024-3205(96)00686-8 · Cited by 50
Allergens and Irritants Transcriptionally Upregulate CD80 Gene Expression in Human Keratinocytes
Wakem, P., Burns, R. P., Ramirez, F., Zlotnick, D., Ferbel, B., Haidaris, C. G., & Gaspari, A. A. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00997.x · Cited by 48
CD4+ T-Cell Induction and Effector Functions: A Comparison of Immunity against Soluble Antigens and Viral Infections
Oxenius, A., Zinkernagel, R. M., & Hengartner, H. (1998) · Advances in immunology · doi:10.1016/s0065-2776(08)60390-9 · Cited by 49
B7–CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge
Zheng, P., Wu, Y. P., Guo, Y., Lee, C., & Liu, Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6284 · Cited by 47
CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis
Liu, S., Liu, Z., Shang, A., Xun, J., Lv, Z., Zhou, S., Liu, C., Zhang, Q., & Yang, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-33915-4 · Cited by 53
Towards the identification of biomarkers of transplantation tolerance
Turka, L. A., & Lechler, R. I. (2009) · Nature reviews. Immunology · doi:10.1038/nri2568 · Cited by 48
“Numerous studies in mice have shown that non-depleting blocking antibodies specific for the co-receptors CD4 and CD8 , and the co-stimulatory receptor CD154, as well as the fusion protein cytotoxic T lymphocyte antigen 4 ( CTLA4 )–immunoglobulin (which binds to the CD28 ligands CD80 and CD86 (Ref”
Background
Indoleamine 2,3‐dioxygenase in transplantation (Review Article)
Mulley, W. R., & Nikolic‐Paterson, D. J. (2008) · Nephrology · doi:10.1111/j.1440-1797.2007.00921.x · Cited by 48
Production and characterization of human CTLA4Ig expressed in transgenic rice cell suspension cultures
Lee, S.-J., Park, C.-I., Park, M.-Y., Jung, H.-S., Ryu, W. S., Lim, S., Tan, H.-K., Kwon, T., Yang, M., & Kim, D. (2006) · Protein Expression and Purification · doi:10.1016/j.pep.2006.08.019 · Cited by 48
Spontaneous production of various cytokines except IL-4 from CD4+ T cells in the affected organs of sarcoidosis patients
Hoshino, T., Itoh, K., Gouhara, R., Yamada, A., Tanaka, Y., Ichikawa, Y., Azuma, M., Mochizuki, M., & Oizumi, K. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03797.x · Cited by 48
Role of the CTLA-4 receptor in t cell activation and immunity
Scheipers, P., & Reiser, H. (1998) · Immunologic Research · doi:10.1007/bf02788753 · Cited by 48
Differential regulation of human T cell responsiveness by mucosal versus blood monocytes
Qiao, L., Braunstein, J., Golling, M. T., Schürmann, G., Autschbach, F., Möller, P., & Meuer, S. C. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260430 · Cited by 48
Checkpoint Blockade for the Treatment of Advanced Melanoma
Callahan, M. K., Flaherty, C., & Postow, M. A. (2015) · Cancer treatment and research · doi:10.1007/978-3-319-22539-5_9 · Cited by 49
Soluble immune checkpoint molecules: Serum markers for cancer diagnosis and prognosis
Chakrabarti, R., Kapse, B., & Mukherjee, G. (2019) · Cancer Reports · doi:10.1002/cnr2.1160 · Cited by 46
Role of immune checkpoint inhibitors in the treatment of colorectal cancer: focus on nivolumab
Jacome, A. A. D. A., & Eng, C. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1680636 · Cited by 47
“stimulatory mechanism for lymphocyte activation [81,82].”
Background
Attachment of Human Immunodeficiency Virus-1 (HIV-1) Particles Bearing Host-encoded B7-2 Proteins Leads to Nuclear Factor-κB- and Nuclear Factor of Activated T Cells-dependent Activation of HIV-1 Long Terminal Repeat Transcription
Bounou, S., Dumais, N., & Tremblay, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m002198200 · Cited by 47
Lipopolysaccharide Effectively Up‐Regulates B7‐1 (CD80) Expression and Costimulatory Function of Human Monocytes
Schmittel, A. H., Scheibenbogen, C., & Keilholz, U. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03714.x · Cited by 47
CD28/CTLA‐4–CD80/CD86 and ICOS–B7RP‐1 costimulatory pathway in bronchial asthma
Chen, Y. ‐., & Shi, H. (2005) · Allergy · doi:10.1111/j.1398-9995.2006.01008.x · Cited by 46
“CTLA-4 is a member of the immunoglobulin gene superfamily and along with its homologue, CD28, is a B7-binding protein (42).”
Background
Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity
Crepeau, R. L., & Ford, M. L. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1333595 · Cited by 46
“Interestingly, although surface expression of CTLA-4 only ever reaches ~1/ 50th that of CD28, its affinity for their common ligands, CD80 and CD86, is ~1000-fold greater [2,9].”
Background
PD-L1 and B7-1 Cis-Interaction: New Mechanisms in Immune Checkpoints and Immunotherapies
Nishimura, C., Pulanco, M. C., Cui, W., Lu, L., & Zang, X. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.10.004 · Cited by 45
Stimulated renal tubular epithelial cells induce anergy in CD4+ T cells
Singer, G. G., Yokoyama, H., Bloom, R. D., Jevnikar, A. M., Nabavi, N., & Kelley, V. R. (1993) · Kidney International · doi:10.1038/ki.1993.345 · Cited by 46
Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy
Hemmann, S., Nikolaizik, W. H., Schöni, M. H., Blaser, K., & Crameri, R. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199804)28:04 · Cited by 131
Stimulatory Effects of B7-Related Protein-1 on Cellular and Humoral Immune Responses in Mice
Guo, J., Stolina, M., BREADY, J. V., Yin, S., Horan, T., Yoshinaga, S. K., & Senaldi, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5578 · Cited by 47
Accessory cell signals regulate Th-cell responses: from basic immunology to a model of helminthic disease
Stadecker, M. J., & Flores-Villanueva, P. O. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90219-4 · Cited by 46
Immunomodulatory Precision: A Narrative Review Exploring the Critical Role of Immune Checkpoint Inhibitors in Cancer Treatment
Qiu, J., Cheng, Z., Jiang, Z., Gan, L., Zhang, Z., & Xie, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105490 · Cited by 53
“The CTLA-4-encoding gene is located on chromosome 2q33, adjacent to the gene encoding the CD28 receptor [63].”
Background
Impaired Proteasome Function Activates GATA3 in T Cells and Upregulates CTLA-4: Relevance for Sézary Syndrome
Gibson, H. M., Mishra, A., Chan, D. V., Hake, T. S., Porcu, P., & Wong, H. K. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.265 · Cited by 45
Armed Therapeutic Viruses – A Disruptive Therapy on the Horizon of Cancer Immunotherapy
Bauzon, M., & Hermiston, T. W. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00074 · Cited by 47
Cry1Ac protoxin from Bacillus thuringiensis promotes macrophage activation by upregulating CD80 and CD86 and by inducing IL-6, MCP-1 and TNF-α cytokines
Moreno‐Fierros, L., García‐Hernández, A. L., Ilhuicatzi-Alvarado, D., Rivera-Santiago, L., Torres‐Martínez, M., Rubio‐Infante, N., & Legorreta‐Herrera, M. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.10.005 · Cited by 45
Coinhibitory Molecules in Autoimmune Diseases
Watanabe, N., & Nakajima, H. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/269756 · Cited by 45
Molecular characterization of U937‐dependent T‐cell co‐stimulation
STONEHOUSE, WOODHEAD, HERRIDGE, ASHRAFIAN, GEORGE, Chain, B., & KATZ (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00670.x · Cited by 45
Costimulation Light: Activation of CD4+ T Cells with CD80 or CD86 Rather Than Anti-CD28 Leads to a Th2 Cytokine Profile
Broeren, C. P. M., Gray, G. S., Carreno, B. M., & June, C. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.6908 · Cited by 45
The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep
Drew, D. R., Boyle, J. S., Lew, A. M., Lightowlers, M. W., Chaplin, P. J., & Strugnell, R. A. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00196-7 · Cited by 45
Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4.
Fargeas, C. A., Truneh, A., Reddy, M. P., Hurle, M. R., Sweet, R. W., & Sékaly, R. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.3.667 · Cited by 45
Helper effector function of human T cells stimulated by anti‐CD3 mAb can be enhanced by co‐stimulatory signals and is partially dependent on CD40‐CD40 ligand interaction
Kwekkeboom, J., de Rijk, D., Kasran, A., Barcy, S., de Groot, C. H., & Boer, M. D. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240303 · Cited by 45
The BB1 Monoclonal Antibody Recognizes Both Cell Surface CD74 (MHC Class II-Associated Invariant Chain) as Well as B7-1 (CD80), Resolving the Question Regarding a Third CD28/CTLA-4 Counterreceptor
Freeman, G. J., Cardoso, A. A., Boussiotis, V. A., Anumanthan, A., Groves, R. W., Kupper, T. S., Clark, E. A., & Nadler, L. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2708 · Cited by 45
Is CTLA-4 a negative regulator for T-cell activation?
Liu, Y. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01170-5 · Cited by 45
Recent highlights in the immunomodulatory aspects of Treg cell-derived extracellular vesicles: special emphasis on autoimmune diseases and transplantation
Asemani, Y., Najafi, S., Ezzatifar, F., Zolbanin, N. M., & Jafari, R. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00808-4 · Cited by 45
“Compared to CD28, the extracellular binding domain of CTLA-4 binds to the B7-1 (CD80) and B7-2 (CD86) on the surface of APCs, albeit with much higher affinity [74, 75].”
Background
Tremelimumab (CP-675,206): a fully human anticytotoxic T lymphocyte-associated antigen 4 monoclonal antibody for treatment of patients with advanced cancers
Tarhini, A. A., & Kirkwood, J. M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.10.1583 · Cited by 44
“CTLA4 has a higher binding affinity than CD28 for B7 [12] ; therefore, CTLA4 outcompetes CD28 for binding to B7.”
Background
Immune checkpoint inhibitor–induced inflammatory arthritis as a model of autoimmune arthritis
Cappelli, L. C., Thomas, M. A., Bingham, C. O., Shah, A. A., & Darrah, E. (2020) · Immunological Reviews · doi:10.1111/imr.12832 · Cited by 45
Abatacept in the treatment of rheumatoid arthritis
Vital, E. M. J., & Emery, P. (2006) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.2006.2.4.365 · Cited by 44
“CD28 signaling mediates expression of IL2 and anti-apoptotic molecules, amongst other effects (Jenkins et al 1991).”
Influential
The role of the BTLA-HVEM complex in the pathogenesis of autoimmune diseases
Wojciechowicz, K., Spodzieja, M., Lisowska, K. A., & Wardowska, A. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104532 · Cited by 45
CD40 ligand supports the long-term maintenance and differentiation of chicken B cells in culture
Kothlow, S., Morgenroth, I., Tregaskes, C. A., Kaspers, B., & Young, J. R. (2008) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2008.01.012 · Cited by 44
Transplantation tolerance: The concept and its applicability
Dong, V. M., Womer, K. L., & Sayegh, M. H. (1999) · Pediatric Transplantation · doi:10.1034/j.1399-3046.1999.00042.x · Cited by 44
“CD28 has a high degree of homology (32% identity at the amino acid level) to another gene called CTLA4 (37).”
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
Fournier, S., Rathmell, J. C., Goodnow, C. C., & Allison, J. P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80335-0 · Cited by 43
Alloreactivity and apoptosis in graft rejection and transplantation tolerance
Zavazava, N., & Kabelitz, D. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.2.167 · Cited by 44
“A CTLA4-immunoglobulin (Ig) fusion protein consisting of the extracellular domain of CTLA4 fused to an Ig has been shown to bind to CD80 with a 20-fold higher affinity than a similar CD28 construct [53].”
Background
Blockage of T-cell costimulation inhibits T-cell action in celiac disease
Maiuri, L., Auricchio, S., Coletta, S., Marco, G. D., Picarelli, A., Tola, M. D., Quaratino, S., & Londei, M. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70135-0 · Cited by 44
PEPTIDES DERIVED FROM ICAM-1 AND LFA-1 MODULATE T CELL ADHESION AND IMMUNE FUNCTION IN A MIXED LYMPHOCYTE CULTURE1
Tibbetts, S. A., Chirathaworn, C., Nakashima, M., JOIS, D. S. S., Siahaan, T. J., Chan, M. A., & Benedict, S. H. (1999) · Transplantation · doi:10.1097/00007890-199909150-00015 · Cited by 44
Immune checkpoint landscape of human atherosclerosis and influence of cardiometabolic factors
Durán, J. G. B., Das, D., Gildea, M. A., Amadori, L., Gourvest, M., Kaur, R., Eberhardt, N., Smyrnis, P., Cılhoroz, B., Sajja, S., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00563-4 · Cited by 48
Dendritic cell activation by polysaccharide isolated from Angelica dahurica
Kim, H. S., Shin, B. R., Lee, H. K., Park, Y. S., Liu, Q., Kim, S. Y., Lee, M. K., Hong, J. T., Kim, Y. S., & Han, S. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.12.007 · Cited by 43
Staphylococcal Superantigens Spark Host-Mediated Danger Signals
Krakauer, T., Pradhan, K., & Stiles, B. G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00023 · Cited by 48
“CTLA4 interacts with costimulatory molecules CD80 and CD86, preventing costimulatory signals in superantigen-activated T cells (146).”
Background
Costimulation blockade: towards clinical application
Timothy, A. W. (2007) · Frontiers in bioscience · doi:10.2741/2829 · Cited by 43
Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma
Wang, X., Zuo, D., Sarkar, D., & Fisher, P. B. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.629187 · Cited by 44
“Upon Tcell activation, CTLA-4 is upregulated and competes with CD28 for binding to B7, thereby transmitting a suppressive signal for T-cell activation [31-33].”
Background
Immunoadhesins
Ashkenazi, A., Capon, D. J., & Ward, R. H. R. (1993) · International Reviews of Immunology · doi:10.3109/08830189309061697 · Cited by 43
Effects of cyclosporin A, FK 506, and mycalamide A on the activation of murine CD4+ T cells by the murine B7 antigen
Galvin, F., Freeman, G. J., Razi-Wolf, Z., D, B. B. M., Nadler, L. M., & Reiser, H. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230145 · Cited by 43
Genomic structure and subcellular localization of MAL, a human T-cell-specific proteolipid protein.
Rancaño, C., Rubio, T., Correas, I., & Alonso, M. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37174-0 · Cited by 43
Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy
Huang, J.-L., Chang, Y.-T., Hong, Z.-Y., & Lin, C.-S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063238 · Cited by 42
Immunotherapies in rare cancers
Vivekanandhan, S., Bahr, D. A., Kothari, A., Ashary, M. A., Baksh, M., & Gabriel, E. M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01720-2 · Cited by 43
“CTLA-4, a structural homologue of CD28 is a membrane receptor on cytotoxic T cells [6].”
Background
Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus
Sthoeger, Z. M., Sharabi, A., & Mozes, E. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.06.002 · Cited by 43
“1; 2), a humanized IgG1 anti-CD22mAb, was shown to reduce (in vitro) the expression of CD22, CD15, CD21 and CD79b on the surface of peripheral B cells obtained from healthy donors and lupus patients.”
BackgroundInfluential
CTLA4Ig Inhibits Effector T Cells through Regulatory T Cells and TGF-β
Deppong, C. M., Bricker, T. L., Rannals, B. D., van Rooijen, N., Hsieh, C., & Green, J. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300830 · Cited by 42
“of B7 proteins with their counterreceptors CD28 and CTLA4 expressed on T cells (7).”
Background
A novel role for coinhibitory receptors/checkpoint proteins in the immunopathology of sepsis
Fallon, E. A., Girard, B., Chung, C., Lomas‐Neira, J., Heffernan, D. S., Monaghan, S. F., & Ayala, A. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mir0917-377r · Cited by 45
Multiplicity of Glucocorticoid Action in Inhibiting Allograft Rejection
Almawi, W. Y., Hess, D. A., & Rieder, M. J. (1998) · Cell Transplantation · doi:10.1016/s0963-6897(98)00042-6 · Cited by 42
Direct regulatory immune activity of lactic acid bacteria on Der p 1–pulsed dendritic cells from allergic patients
Pochard, P., Hammad, H., Ratajczak, C., Charbonnier, A.-S., Just, N., Tonnel, A., & Pestel, J. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.037 · Cited by 42
Exaggerated and persistent cutaneous delayed-type hypersensitivity in transgenic mice whose epidermal keratinocytes constitutively express B7-1 antigen.
Nasir, A., Ferbel, B., Salminen, W. F., Barth, R. K., & Gaspari, A. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117411 · Cited by 42
Regulation of Expression of B7 by Murine Langerhans Cells: A Direct Relationship Between B7 mRNA Levels and the Level of Surface Expression of B7 by Langerhans Cells
Lee, M., Borkowski, T. A., & Udey, M. C. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371712 · Cited by 42
Immunobiology and immunopharmacology of organ allograft rejection
Suthanthiran, M., & Strom, T. B. (1995) · Journal of Clinical Immunology · doi:10.1007/bf01541085 · Cited by 42
Human Neutrophil-Expressed CD28 Interacts with Macrophage B7 to Induce Phosphatidylinositol 3-Kinase-Dependent IFN-γ Secretion and Restriction of Leishmania Growth
Venuprasad, K., Banerjee, P. P., Chattopadhyay, S., Sharma, S., Pal, S., Parab, P. B., Mitra, D., & Saha, B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.920 · Cited by 42
“major-infected macrophages in the presence or absence of CTLA4-Ig, a fusion protein that blocks the CD28-CD80/CD86 interaction (14).”
Background
Presentation of peptides and proteins by intestinal epithelial cells.
Hoyne, G. F., Callow, M. G., Kuo, M. C., & Thomas, W. R. (1993) · PubMed Central · Cited by 42
The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition
van Dorp, J., & van der Heijden, M. S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1235884 · Cited by 42
“By blocking the CTLA-4 receptor with monoclonal antibodies such as ipilimumab and tremelimumab, this inhibitory response can be negated, allowing for binding of CD80 or CD86 with CD28 to costimulate T-cell activation (11, 14).”
Background
Ipilimumab (Yervoy) and the TGN1412 catastrophe
Bakács, T., Mehrishi, J. N., & Moss, R. W. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.07.005 · Cited by 41
Costimulation Blockade in Kidney Transplantation
Malvezzi, P., Jouvé, T., & Rostaing, L. P. E. (2016) · Transplantation · doi:10.1097/tp.0000000000001344 · Cited by 41
Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1
Cox, L. S. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199710)183:2 · Cited by 115
CTLA4Ig combined with anti-LFA-1 prolongs cardiac allograft survival indefinitely
Corbascio, M., Ekstrand, H., Österholm, C., Qi, Z., Simanaitis, M., Larsen, C. P., Pearson, T. C., Riesbeck, K., & Ekberg, H. (2002) · Transplant Immunology · doi:10.1016/s0966-3274(02)00014-x · Cited by 41
PROTECTIVE EFFECT OF CTLA4Ig SECRETED BY TRANSGENIC FETAL PANCREAS ALLOGRAFTS1
Sutherland, R. M., Brady, J. L., Georgiou, H. M., Thomas, H. E., & Lew, A. M. (2000) · Transplantation · doi:10.1097/00007890-200005150-00013 · Cited by 41
BLOCKADE OF MULTIPLE COSTIMULATORY RECEPTORS INDUCES HYPORESPONSIVENESS
Woodward, J. E., Qin, L., Chavin, K. D., Lin, J., Tono, T., Ding, Y., Linsley, P. S., Bromberg, J. S., & Baliga, P. K. (1996) · Transplantation · doi:10.1097/00007890-199610150-00021 · Cited by 41
Self-citation
Elevated CTLA-4 expression on CD4 T cells from periodontitis patients stimulated withPorphyromonas gingivalisouter membrane antigen
Aoyagi, T., Yamazaki, K., Kabasawa-Katoh, Y., Nakajima, T. E., Yamashita, N., Yoshie, H., & Hara, K. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01126.x · Cited by 41
Two signaling pathways can lead to Fas ligand expression in CD8+ cytotoxic T lymphocyte clones
Anel, A., Simon, A. K., Auphan‐Anezin, N., Buferne, M., Boyer, C., Golstein, P., & Schmitt‐Verhulst, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251227 · Cited by 41
Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors.
Haffar, O. K., Smithgall, M. D., Bradshaw, J., Brady, B., Damle, N. K., & Linsley, P. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11094 · Cited by 41
Self-citation
T–cell anergy and peripheral T–cell tolerance
Lechler, R. I., Chai, J., Marelli‐Berg, F. M., & Lombardi, G. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2001.0844 · Cited by 41
Costimulation and its role in organ transplantation
Bluestone, J. A. (1996) · Clinical Transplantation · doi:10.1111/j.1399-0012.1996.tb00655.x · Cited by 41
Identification of anti-inflammatory target genes of Rhizoma coptidis extract in lipopolysaccharide-stimulated RAW264.7 murine macrophage-like cells
Kim, J. M., Jung, H. A., Choi, J. S., & Lee, N. G. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.05.022 · Cited by 39
Structure–Function Analysis of Immune Checkpoint Receptors to Guide Emerging Anticancer Immunotherapy
Acúrcio, R. C., Scomparin, A., Conniot, J., Salvador, J. A. R., Satchi‐Fainaro, R., Florindo, H. F., & Guedes, R. C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00541 · Cited by 40
Intrinsic cancer vaccination
Yang, Y., Nam, G., Kim, G. B., Kim, Y. K., & Kim, I. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.007 · Cited by 40
Past, Present, and Future of Anticancer Nanomedicine
Kim, K., & Khang, D. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s254774 · Cited by 39
Selective Costimulation Modulators
Kremer, J. M. (2005) · JCR Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000166626.68898.17 · Cited by 40
“2A).(15) The CTLA4 domain, similar to the naturally occurring protein, avidly binds to CD80/CD86 on APCs.”
Background
Immune modulation in corneal transplantation
Fu, H., Larkin, F., & George, A. J. T. (2008) · Transplantation Reviews · doi:10.1016/j.trre.2007.12.005 · Cited by 40
“Cytotoxic T-lymphocyte antigen 4 (CD152), the alternative T cell ligand for B7, is an inhibitory receptor limiting T-cell activation [50,51].”
Background
The CD28-B7 costimulatory pathway and its role in autoimmune disease
Daikh, D., Wofsy, D., & Imbodent, J. B. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.2.156 · Cited by 40
Targeting Memory T Cells in Type 1 Diabetes
Ehlers, M. R., & Rigby, M. R. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0659-5 · Cited by 40
Acoustic and electrical activities during voluntary isometric contraction of biceps brachii muscles in patients with spastic cerebral palsy
Akataki, K., Mita, K., Itoh, K., Suzuki, N., & Watakabe, M. (1996) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199610)19:10 · Cited by 81
Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): Analysis by site directed mutagenesis
Truneh, A. (1996) · Molecular Immunology · doi:10.1016/0161-5890(95)00077-1 · Cited by 40
Accessory cell-derived signals required for T cell activation
Johnson, J. G., & Jenkins, M. K. (1993) · Immunologic Research · doi:10.1007/bf02918368 · Cited by 40
IMMUNOTHERAPY WITH NONDEPLETING ANTI-CD4 MONOCLONAL ANTIBODIES BUT NOT CD28 ANTAGONISTS PROTECTS ISLET GRAFT IN SPONTANEOUSLY DIABETIC NOD MICE FROM AUTOIMMUNE DESTRUCTION AND ALLOGENEIC AND XENOGENEIC GRAFT REJECTION1
Guo, Z., Wu, T., Kirchhof, N., Mital, D., Williams, J. W., Azuma, M., Sutherland, D. E. R., & Hering, B. J. (2001) · Transplantation · doi:10.1097/00007890-200106150-00027 · Cited by 40
Role of the CD28-B7 Costimulatory Pathways in T Cell-Dependent B Cell Responses
Hathcock, K. S., & Hodes, R. J. (1996) · Advances in immunology · doi:10.1016/s0065-2776(08)60429-0 · Cited by 39
Local Costimulation Reinvigorates Tumor-Specific Cytolytic T Lymphocytes for Experimental Therapy in Mice with Large Tumor Burdens
Bai, X., Bender, J. D., Liu, J., Zhang, H., Wang, Y., Ou, L., Du, P., Zheng, P., & Liu, Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3936 · Cited by 40
“Alternatively, one may attempt to bypass such a requirement by activating B7 receptors, CD28 and CTLA4.”
BackgroundInfluential
Immune checkpoints aberrations and gastric cancer; assessment of prognostic value and evaluation of therapeutic potentials
Abdel-Rahman, O. M. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.08.015 · Cited by 39

Authors: Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K., & Ledbetter, J. A.
Affiliations: Bristol-Myers Squibb (United States) (US)
ORCID: Linsley, P S
Venue: The Journal of experimental medicine
Publisher: Rockefeller University Press
Published: 1991-09-01
Volume: 174
Issue: 3
Pages: 561-569
ISSN: 0022-1007 (ISSN-L)
1540-9538
DOI: 10.1084/jem.174.3.561
PMC: PMC2118936
OpenAlex: W2087013294
Cited by: 1,685
References: 41
Citations by year: 2026: 14 · 2025: 31 · 2024: 49 · 2023: 37 · 2022: 35 · 2021: 49 · 2020: 51 · 2019: 55 · 2018: 49 · 2017: 49 · 2016: 59 · 2015: 52 · 2014: 39 · 2013: 41 · 2012: 39
FWCI: 27.78
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: The Journal of Experimental Medicine (publishedVersion)
PubMed Central (publishedVersion, cc-by-nc-sa)
PubMed (publishedVersion)
Funders: Bristol-Myers Squibb
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: CTLA-4, B7, CD28, T cell costimulation, B cell activation, T cell-B cell interaction, soluble receptor, interleukin-2, alloantigen response, cytotoxic T lymphocytes
MeSH terms: Abatacept, Amino Acid Sequence, Animals, Antigens, Differentiation, Antigens, Surface, B-Lymphocytes, Base Sequence, Cell Line, Ligands, Lymphocyte Cooperation, Lymphocyte Activation, Molecular Sequence Data, Oligonucleotides, Precipitin Tests, Receptors, Immunologic, Recombinant Fusion Proteins, T-Lymphocytes, Antigens, CD, B7-1 Antigen, Immunoconjugates, CTLA-4 Antigen, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

CTLA-4 is a second receptor for the B cell activation antigen B7.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks